These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 15619115)

  • 41. LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress.
    Schoepp DD; Wright RA; Levine LR; Gaydos B; Potter WZ
    Stress; 2003 Sep; 6(3):189-97. PubMed ID: 13129812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection.
    Corti C; Battaglia G; Molinaro G; Riozzi B; Pittaluga A; Corsi M; Mugnaini M; Nicoletti F; Bruno V
    J Neurosci; 2007 Aug; 27(31):8297-308. PubMed ID: 17670976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Individual contribution of metabotropic glutamate receptor (mGlu) 2 and 3 to c-Fos expression pattern evoked by mGlu2/3 antagonism.
    Hetzenauer A; Corti C; Herdy S; Corsi M; Ferraguti F; Singewald N
    Psychopharmacology (Berl); 2008 Nov; 201(1):1-13. PubMed ID: 18813914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anxiolytic action of group II and III metabotropic glutamate receptors agonists involves neuropeptide Y in the amygdala.
    Wierońska JM; Szewczyk B; Pałucha A; Brański P; Zieba B; Smiałowska M
    Pharmacol Rep; 2005; 57(6):734-43. PubMed ID: 16382191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
    Koltunowska D; Gibula-Bruzda E; Kotlinska JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():242-9. PubMed ID: 23623810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells.
    Johnson BG; Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
    Neuropharmacology; 1999 Oct; 38(10):1519-29. PubMed ID: 10530814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of group II metabotropic glutamate receptors by G protein-coupled receptor kinases: mGlu2 receptors are resistant to homologous desensitization.
    Iacovelli L; Molinaro G; Battaglia G; Motolese M; Di Menna L; Alfiero M; Blahos J; Matrisciano F; Corsi M; Corti C; Bruno V; De Blasi A; Nicoletti F
    Mol Pharmacol; 2009 Apr; 75(4):991-1003. PubMed ID: 19164443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes.
    Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):546-54. PubMed ID: 11138847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transepithelial transport of the group II metabotropic glutamate 2/3 receptor agonist (1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate (LY354740) and its prodrug (1S,2S,5R,6S)-2-[(2'S)-(2'-amino)propionyl]aminobicyclo[3.1.0]hexane-2,6-dicarboxylate (LY544344).
    Varma MV; Eriksson AH; Sawada G; Pak YA; Perkins EJ; Zimmerman CL
    Drug Metab Dispos; 2009 Jan; 37(1):211-20. PubMed ID: 18838508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala.
    Neugebauer V; Zinebi F; Russell R; Gallagher JP; Shinnick-Gallagher P
    J Neurophysiol; 2000 Aug; 84(2):759-70. PubMed ID: 10938303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
    Koike H; Iijima M; Chaki S
    Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTPgammas binding.
    Richards G; Messer J; Malherbe P; Pink R; Brockhaus M; Stadler H; Wichmann J; Schaffhauser H; Mutel V
    J Comp Neurol; 2005 Jun; 487(1):15-27. PubMed ID: 15861463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. mGlu2/3 receptor agonist (LY354740) in anxiety.
    Schoepp DD
    Pharmacol Biochem Behav; 2024 Sep; 242():173826. PubMed ID: 39025335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists.
    Zammataro M; Chiechio S; Montana MC; Traficante A; Copani A; Nicoletti F; Gereau RW
    Mol Pain; 2011 Jan; 7():6. PubMed ID: 21235748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord.
    Howson PA; Jane DE
    Br J Pharmacol; 2003 May; 139(1):147-55. PubMed ID: 12746233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2017 Mar; 115():115-127. PubMed ID: 28216000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata.
    Johnson KA; Niswender CM; Conn PJ; Xiang Z
    Neurosci Lett; 2011 Oct; 504(2):102-106. PubMed ID: 21945652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties.
    Monn JA; Valli MJ; Massey SM; Wright RA; Salhoff CR; Johnson BG; Howe T; Alt CA; Rhodes GA; Robey RL; Griffey KR; Tizzano JP; Kallman MJ; Helton DR; Schoepp DD
    J Med Chem; 1997 Feb; 40(4):528-37. PubMed ID: 9046344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine.
    Schreiber R; Lowe D; Voerste A; De Vry J
    Eur J Pharmacol; 2000 Jan; 388(2):R3-4. PubMed ID: 10666513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
    Vandergriff J; Rasmussen K
    Neuropharmacology; 1999 Feb; 38(2):217-22. PubMed ID: 10218862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.